Joint Formulary & PAD

Amisulpride - Schizophrenia and other psychoses

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Blue
Formulations :
  • Oral solution
  • Tablets
Associated Icons :
SPC
Restrictions / Comments :
Important

Second line treatment option in the management of schizophrenia once metabolic syndrome has been identified.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Amisulpride
Indication :
Schizophrenia and other psychoses
Group Name :
Keywords :
antipsychotics
Brand Names Include :
Important Information :

Initiation by a SABP specialist and stabilisation for at least 3 months before any request to transfer prescribing responsibility.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Amisulpride is used to treat.

Committee Recommendations (0)

  • No records returned.